To dance problems/dance adversities. The dance as the strategy of dealing with

Celem pracy „Przetańczyć trudności/przetańczyć przeciwności losu. Taniec jako strategia radzenia sobie” jest przedstawienie tańca jako strategii radzenia sobie z trudnościami w przypadku osób niewidomych, niedostosowanych społecznie/wykluczonych oraz osób mających trudności z wychowankami/prowadzących zajęcia. Poszczególne grupy zostały scharakteryzowane z uwzględnieniem sytuacji życiowej, doświadczanych trudności oraz strategii radzenia sobie z nimi w przypadku każdej z nich.W celu uzyskania odpowiedzi na problemy i pytania badawcze przeprowadzono analizę literatury, wywiady z przedstawicielami danych grup, obserwacje zajęć tanecznych oraz analizę treści (filmów).Praca zawiera również odniesienie do historii i zastosowania samego tańca w życiu człowieka z uwzględnieniem jego zastosowania w przypadku wybranych grup badawczych.The purpose of the Master's thesis: "To dance problems/dance adversities. The dance as the strategy of dealing with" is presenting the dance as the strategy of dealing problems with is in case of blind, unsuited socially/excluded and persons having difficulty from alumnus/ person giving classes. Individual groups were characterised including the their situation in life, of experienced problems and of strategy of dealing them with in case of every of them.In the destination of obtaining the response to the problems and research questions were conducted: analysis of literature, interviews with representatives of given groups, observation of dance classes and analysis of the plot (of films).A master's thesis contains also taking back to history and application of the dance in the life of the man including using it in case of chosen research groups

Formal Comparison of Copula-AR(1)-t-GARCH(1,1) Models for Sub-Indices of the Stock Index WIG

Kopule stały się jednym z popularnych narzędzi modelowania zależności między szeregami czasowymi, pochodzącymi z rynków finansowych. Głównym celem pracy jest formalne, bayesowskie porównanie mocy wyjaśniającej dwuwymiarowych modeli Copula-AR-GARCH, różniących się strukturą zależności warunkowych, opisaną przez poszczególne kopule. Dla porównania dokonano również estymacji modeli Copula-AR-GARCH metodą największej wiarygodności, a następnie zbudowano ranking modeli na podstawie kryteriów informacyjnych Akaikego (AIC) oraz Schwarza (BIC). Modele CopulaAR-GARCH zostały wykorzystane do opisu zmienności i zależności dziennych stóp zwrotu subindeksów indeksu WIG. Wyniki wskazały na dużą przydatność bardzo prostych i nieformalnych metod porównywania modeli Copula-AR-GARCH. Dla sześciu par szeregów czasowych rankingi modeli uzyskane metodami formalnymi (w ujęciu bayesowskim) i metodami ad hoc (poprzez AIC i BIC) okazały się bardzo zbliżone, a w wielu przypadkach identyczne.Copulas have become one of most popular tools used in modelling the dependencies among financial time series. The main aim of the paper is to formally assess the relative explanatory power of competing bivariate Copula-AR-GARCH models, which differ in assumptions on the conditional dependence structure represented by particular copulas. For the sake of comparison the Copula-AR-GARCH models are estimated using the maximum likelihood method, and next they are informally compared and ranked according to the values of the Akaike (AIC) and of the Schwarz (BIC) information criteria. We apply these tools to the daily growth rates of four sub-indices of the stock index WIG published by the Warsaw Stock Exchange. Our results indicate that the informal use of the information criteria (AIC or BIC) leads to very similar ranks of models as compared to those obtained by the use of the formal Bayesian model comparison

MODELING STNOCK MARKET INDEXES WITH COPULA FUNCTIONS (Zastosowanie funkcji kopuli w modelowaniu indeksów gieldowych)

Contemporary financial risk management is significantly based on the analysis of time series of returns. One of the most significant errors frequently committed by analysts is the predominant use of normal distributions when it is clear that the returns are not normal. Copula models and models for non-normal multivariate distributions provide new tools to solve the problem because the obtained results are immediately applicable in portfolio management, option pricing and measuring risk without assuming normality. Therefore, both a theoretician and a practitioner are interested in multivariate models for returns and copula functions. The copula function models provide an effective and interesting technique of constructing multivariate distribution starting from marginal ones. Due to Sklar's result established in 1959, we can present any multivariate distribution with a help of corresponding marginal distributions and a selected copula function. In this work we present an application of copula function to construct multivariate conditional distributions of times series. In the last part of this paper dynamic models such as DCC-MVGARCH and conditional copula are analyzed. Moreover, we also present an application of bootstrap in the context of copula function. This work is appended by examples showing practical application of our work

Are EPA and DHA Derivatives Involved in IBD Remission?

Recently, an increase in the incidence of inflammatory bowel disease (IBD) has been observed among children and adolescents. Although the pathogenesis of IBD is not fully elucidated currently, actual research focuses on the occurrence of imbalance between pro- and anti-inflammatory molecules and future identification of the role of cytokines in IBD therapy. The purpose of this study was to compare the concentrations of eicosapentaenoic and docosahexaenoic acid derivatives during both phases of Crohn’s disease (CD) and ulcerative colitis (UC). The study included 64 adolescent patients with CD (n = 34) and UC (n = 30) aged 13.76 ± 2.69 and 14.15 ± 3.31, respectively. Biochemical analysis was performed on a liquid chromatography apparatus. A statistically significant lower concentration of resolvin E1 (RvE1) was observed in the CD group relative to UC. In the active phase of CD, a statistically significantly higher concentration of protectin DX (PDX) was observed relative to remission CD. Comparing the active phase of both diseases, a statistically significantly higher concentration of resolvin E1 (RvE1) was observed in UC relative to CD. Comparing the remission phase of both diseases showed statistically significantly higher PDX levels in CD relative to UC. Our study adds to the knowledge on the involvement of anti-inflammatory lipid mediators in both IBD entities. In conclusion, it seems that the marker differentiating both disease entities in the active phase may be RvE1, while in the remission phase, PDX. In CD remission, the greatest involvement was observed towards PDX, whereas in UC, MaR1, RvE1 and 18RS-HEPE seem to be the most involved in remission

Involvement of Proinflammatory Arachidonic Acid (ARA) Derivatives in Crohn’s Disease (CD) and Ulcerative Colitis (UC)

Recently, an increase in the incidence of inflammatory bowel disease (IBD) has been observed, especially among children and adolescents. Currently, few studies focus on the differentiation of inflammation in IBD subunits, i.e., Crohn’s Disease (CD) and Ulcerative Colitis (UC). The aim of this study was to compare the concentrations of proinflammatory mediators of arachidonic acid (ARA) and linoleic acid (LA) in patients with CD (n = 34) and UC (n = 30), in order to identify differences in inflammation in both diseases and within the same entity, according to disease activity. Sixty-four adolescents with a mean age of 13.76 ± 2.69 and 14.15 ± 3.31, for CD and UC, respectively, were enrolled in the study. Biochemical analysis of ARA and LA derivatives was performed using a liquid chromatography. A trend was observed in the concentration of 15S-HETE (hydroxyeicosatetraenoic acids) in CD relative to UC. The active phase of both diseases showed a higher 15S-HETE concentration in active CD relative to active UC. Comparing patients with CD with active and inactive disease showed a trend of increased levels of thromboxane B2, leukotriene B4 and 9S-HODE (hydroxyoctadecadienoic acid) in the active versus the inactive disease. We also observed statistically significantly higher levels of 12S-HETE in inactive CD relative to active CD. In the UC group, on the other hand, statistically significantly higher levels of prostaglandin E2 and 16RS-HETE were observed in active UC relative to inactive UC. Moreover, significantly higher concentrations of LTX A4 5S, 6R were observed in inactive UC relative to the active phase. In conclusion, the present study indicated the activity of the 15-LOX pathway in CD. Further studies involving lipid mediators in patients with IBD may contribute to the development of new therapies for the treatment of IBD. The identification of differences in the course of inflammation may help to target therapy in CD and UC, and perhaps allow the introduction of an additional diagnostic marker between the two main IBD subtypes

Involvement of Proinflammatory Arachidonic Acid (ARA) Derivatives in Crohn’s Disease (CD) and Ulcerative Colitis (UC)

Recently, an increase in the incidence of inflammatory bowel disease (IBD) has been observed, especially among children and adolescents. Currently, few studies focus on the differentiation of inflammation in IBD subunits, i.e., Crohn’s Disease (CD) and Ulcerative Colitis (UC). The aim of this study was to compare the concentrations of proinflammatory mediators of arachidonic acid (ARA) and linoleic acid (LA) in patients with CD (n = 34) and UC (n = 30), in order to identify differences in inflammation in both diseases and within the same entity, according to disease activity. Sixty-four adolescents with a mean age of 13.76 ± 2.69 and 14.15 ± 3.31, for CD and UC, respectively, were enrolled in the study. Biochemical analysis of ARA and LA derivatives was performed using a liquid chromatography. A trend was observed in the concentration of 15S-HETE (hydroxyeicosatetraenoic acids) in CD relative to UC. The active phase of both diseases showed a higher 15S-HETE concentration in active CD relative to active UC. Comparing patients with CD with active and inactive disease showed a trend of increased levels of thromboxane B2, leukotriene B4 and 9S-HODE (hydroxyoctadecadienoic acid) in the active versus the inactive disease. We also observed statistically significantly higher levels of 12S-HETE in inactive CD relative to active CD. In the UC group, on the other hand, statistically significantly higher levels of prostaglandin E2 and 16RS-HETE were observed in active UC relative to inactive UC. Moreover, significantly higher concentrations of LTX A4 5S, 6R were observed in inactive UC relative to the active phase. In conclusion, the present study indicated the activity of the 15-LOX pathway in CD. Further studies involving lipid mediators in patients with IBD may contribute to the development of new therapies for the treatment of IBD. The identification of differences in the course of inflammation may help to target therapy in CD and UC, and perhaps allow the introduction of an additional diagnostic marker between the two main IBD subtypes